{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:04:06Z","timestamp":1783937046943,"version":"3.55.0"},"reference-count":25,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Background: In Saudi Arabia, the government has implemented compulsory premarital screening and consultations for high-risk and positive sickle cell results (traits = AS gene and disease = SS gene). However, despite these measures being in place since 2004, there are still cases of children being born with sickle cell disease. This study aims to evaluate the costs associated with the government\u2019s mandatory premarital screening for sickle cell anemia, compare these expenses with those incurred due to high-risk marriages and analyze the government\u2019s healthcare spending on sickle cell anemia management. Method: A decision tree model was conceptualized for the purpose of this study to identify the possible paths from the premarital screening (PMS) procedure. A total of 300,000 cases were processed through this decision tree model. Results: The annual management costs for children with the probability of having sickle cell disease are estimated to be USD 10,746,450 in the screening arm and USD 40,488,000 in the no-screening arm. These costs vary depending on the genetic combination of the parents. For individuals with the SS\/SS gene combination, the estimated cost is USD 8,137,800 per year. When parents have the SS\/AS gene combination, the estimated cost is USD 2,071,950 annually. For those with the sickle cell trait combination (AS\/AS), the cost is estimated to be USD 536,700 per year. A direct comparison shows a modeled PMS incremental cost is estimated at USD 29,741,550, which is approximately a 73% reduction in healthcare costs. Conclusions: The premarital screening for sickle cell disease is not only cost-saving but also shows the potential for significantly reducing healthcare spending related to sickle cell disease in the future.<\/jats:p>","DOI":"10.3390\/healthcare13172243","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:51:12Z","timestamp":1757332272000},"page":"2243","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Economic Impact of Premarital Screening (PMS) of Sickle Cell Anemia on the Saudi Health System: A Cost Analysis Study"],"prefix":"10.3390","volume":"13","author":[{"given":"Amal F.","family":"Alotaibi","sequence":"first","affiliation":[{"name":"Pharmaceutical Practices Department, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami A.","family":"Almalki","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Department, King Faisal Hospital, Makkah Healthcare Cluster, Makkah 24382, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6973-5676","authenticated-orcid":false,"given":"Mona Y.","family":"Alsheikh","sequence":"additional","affiliation":[{"name":"Pharmacy Practice Department, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghufran O.","family":"Omran","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Department, King Faisal Hospital, Makkah Healthcare Cluster, Makkah 24382, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana A.","family":"Althobaiti","sequence":"additional","affiliation":[{"name":"Pharmaceutical Practices Department, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6999-2958","authenticated-orcid":false,"given":"Wejdan S.","family":"AlQurashi","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hematology Unit, King Faisal Hospital, Makkah Healthcare Cluster, Makkah 24382, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"ref_1","unstructured":"Ministry of Health (2025, August 23). Premarital Screening, Available online: https:\/\/www.moh.gov.sa\/en\/HealthAwareness\/Beforemarriage\/Pages\/default.aspx."},{"key":"ref_2","unstructured":"Petrou, M. (2013). Genetic Counselling. Prevention of Thalassaemias and Other Haemoglobin Disorders: Volume 1: Principles [Internet], Thalassaemia International Federation. [2nd ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1258\/jms.2008.008029","article-title":"Premarital Screening Programmes for Haemoglobinopathies, HIV and Hepatitis Viruses: Review and Factors Affecting Their Success","volume":"16","author":"Alswaidi","year":"2009","journal-title":"J. Med. Screen"},{"key":"ref_4","unstructured":"Executive Board, 118 (2025, July 03). Thalassaemia and Other Haemoglobinopathies: Report by the Secretariat, 2006, Executive Board 118th Session, Provisional Agenda Item 5.2. Available online: https:\/\/iris.who.int\/handle\/10665\/21519."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/0256-4947.81540","article-title":"Epidemiology of Sickle Cell Disease in Saudi Arabia","volume":"31","author":"Jastaniah","year":"2011","journal-title":"Ann. Saudi Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jegh.2011.06.002","article-title":"Marked Regional Variations in the Prevalence of Sickle Cell Disease and \u03b2-Thalassemia in Saudi Arabia: Findings from the Premarital Screening and Genetic Counseling Program","volume":"1","author":"Memish","year":"2011","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s44197-024-00281-x","article-title":"Prevalence and Regional sDistribution of Beta-Hemoglobin Variants in Saudi Arabia: Insights from the National Premarital Screening Program","volume":"14","author":"Aljabry","year":"2024","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4103\/0256-4947.81527","article-title":"Six-Year Outcome of the National Premarital Screening and Genetic Counseling Program for Sickle Cell Disease and \u03b2-Thalassemia in Saudi Arabia","volume":"31","author":"Memish","year":"2011","journal-title":"Ann. Saudi Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jegh.2017.12.001","article-title":"Distribution of Hemoglobinopathy Disorders in Saudi Arabia Based on Data from the Premarital Screening and Genetic Counseling Program, 2011\u20132015","volume":"7","author":"Alsaeed","year":"2018","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.24911\/JBCGenetics\/183-1595487640","article-title":"Prevention of Hemoglobinopathies in Saudi Arabia: Efficacy of National Premarital Screening and the Feasibility of Preimplantation Genetic Diagnosis","volume":"3","author":"Umair","year":"2020","journal-title":"J. Biochem. Clin. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jegh.2016.12.006","article-title":"Sickle Cell Disease in Saudi Arabia: A Challenge or Not","volume":"7","author":"Alotaibi","year":"2017","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jiph.2019.06.001","article-title":"National Screening Programs in Saudi Arabia: Overview, Outcomes, and Effectiveness","volume":"12","author":"Gosadi","year":"2019","journal-title":"J. Infect. Public Health"},{"key":"ref_13","unstructured":"(2025, August 26). Premarital Screening\u2014Accredited Premarital Screening Centers, Available online: https:\/\/www.moh.gov.sa\/en\/HealthAwareness\/Beforemarriage\/Pages\/002.aspx."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1509501","DOI":"10.1155\/2020\/1509501","article-title":"Epidemiology of Thalassemia in Gulf Cooperation Council Countries: A Systematic Review","volume":"2020","author":"Heena","year":"2020","journal-title":"BioMed Res. Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.jval.2018.07.826","article-title":"The Economic Burden of Sickle Cell Disease in the United States","volume":"21","author":"Huo","year":"2018","journal-title":"Value Health"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s41669-022-00330-w","article-title":"Medical and Non-Medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis","volume":"6","author":"Baldwin","year":"2022","journal-title":"PharmacoEconomics Open"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.36469\/jheor.2020.12852","article-title":"Medical Resource Use and Costs of Treating Sickle Cell-Related Vaso-Occlusive Crisis Episodes: A Retrospective Claims Study","volume":"7","author":"Shah","year":"2020","journal-title":"J. Health Econ. Outcomes Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jval.2021.02.014","article-title":"Indirect Economic Burden of Sickle Cell Disease","volume":"24","author":"Holdford","year":"2021","journal-title":"Value Health"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101038","DOI":"10.1016\/j.vhri.2024.101038","article-title":"Economic Burden of Sickle Cell Disease in Saudi Arabia","volume":"45","author":"Shdaifat","year":"2025","journal-title":"Value Health Reg. Issues"},{"key":"ref_20","unstructured":"Ministry of Health (2025, August 26). MOH News. MOH Obtains First Place in Institutional Excellence in Spending Efficiency, Available online: https:\/\/www.moh.gov.sa\/en\/Pages\/Default.aspx."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/GIM.0b013e318065a9e8","article-title":"Premarital Screening for Thalassemia and Sickle Cell Disease in Saudi Arabia","volume":"9","author":"AlHamdan","year":"2007","journal-title":"Genet. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"AlRuthia, Y. (2025). The Direct Medical Costs of Sickle Cell Disease in Saudi Arabia: Insights from a Single Center Study. Healthcare, 13.","DOI":"10.3390\/healthcare13040420"},{"key":"ref_23","unstructured":"The United Nations Development Programme (UNDP) (2025, August 26). The Cost of Health Services Delivered at Primary Care Facilities in SAUDI ARABIA. Available online: www.undp.org\/sites\/g\/files\/zskgke326\/files\/2024-02\/ksa_phc_costing_report.pdf."},{"key":"ref_24","unstructured":"Kaushansky, K., Prchal, J.T., Burns, L.J., Lichtman, M.A., Levi, M., and Linch, D.C. (2021). Disorders of Hemoglobin Structure: Sickle Cell Anemia and Related Abnormalities. Williams Hematology, 10e, McGraw-Hill Education."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.56557\/upjoz\/2022\/v43i243315","article-title":"Prevalence of Sickle-Cell Disease in Saudi Arabia: A Systematic Review","volume":"46","author":"Asraf","year":"2022","journal-title":"Uttar Pradesh J. Zool."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/13\/17\/2243\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:41:58Z","timestamp":1760035318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/13\/17\/2243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":25,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["healthcare13172243"],"URL":"https:\/\/doi.org\/10.3390\/healthcare13172243","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]}}}